Robert Wilcox
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Acute Myocardial Infarction Research 2
- Heart Failure Treatment and Management 1
-
- Diabetes Treatment and Management 3
- Co-authors
- Stuart Kupfer (2 shared papers)John Dormandy (2 shared papers)Guntram Schernthaner (1 shared paper)D. J. Betteridge (1 shared paper)Marie‐Germaine Bousser (1 shared paper)Valdis Pīrāgs (1 shared paper)Erland Erdmann (1 shared paper)David A. Morrow (2 shared papers)
- Journals
- European Heart Journal (2 papers)The Lancet (1 paper)Journal of Thrombosis and Thrombolysis (1 paper)Stroke (1 paper)Journal of Cardiac Failure (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Robert Wilcox
10 papers receiving 737 citations
Peers
Comparison fields: 5 of 48
- Endocrinology, Diabetes and Metabolism 290
- Cardiology and Cardiovascular Medicine 240
- Epidemiology 133
- Hematology 54
- Neurology 15
Countries citing papers authored by Robert Wilcox
This map shows the geographic impact of Robert Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wilcox more than expected).
Fields of papers citing papers by Robert Wilcox
This network shows the impact of papers produced by Robert Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wilcox. The network helps show where Robert Wilcox may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Wilcox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 383 | |
| 2 | 2012 | 180 | |
| 3 | 2008 | 104 | |
| 4 | 2010 | 40 | |
| 5 | 1997 | 28 | |
| 6 | 2014 | 16 | |
| 7 | PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study | 2007 | 15 |
| 8 | 2006 | 14 | |
| 9 | 2014 | 7 | |
| 10 | 2000 | 2 |
About Robert Wilcox
Robert Wilcox is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Hematology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 10 papers that have together received 789 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Diabetes Treatment and Management (3 papers), Acute Myocardial Infarction Research (2 papers), Heart Failure Treatment and Management (1 paper) and Blood Coagulation and Thrombosis Mechanisms (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (290 citations), Cardiology and Cardiovascular Medicine (240 citations), Epidemiology (133 citations), Hematology (54 citations) and Neurology (15 citations). Robert Wilcox has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Stuart Kupfer, John Dormandy, Guntram Schernthaner, D. J. Betteridge, Marie‐Germaine Bousser, Valdis Pīrāgs, Erland Erdmann, David A. Morrow, Frans Van de Werf and Chamila M. Geeganage. Their work appears in journals such as European Heart Journal, The Lancet, Journal of Thrombosis and Thrombolysis, Stroke and Journal of Cardiac Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.